ChAdOx1 nCoV-19
Part of: GS Prelims and Mains III – Science – Health and Medicine; Recent developments/advancements
In news:
- ChAdOx1 nCoV-19 is Oxford University’s experimental COVID-19 vaccine.
- According to Lancet study, the vaccine candidate produced neutralising antibodies and boosted the immune system as well.
- According to the Scientists, increasing T-cell response as well as antibodies could be very important in controlling COVID-19.
